P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model

Bauer, CSterzik, ABauernfeind, FDuewell, PConrad, CKiefl, REndres, SEigler, ASchnurr, MDauer, M2014-07-072014Bauer, C, A Sterzik, F Bauernfeind, P Duewell, C Conrad, R Kiefl, S Endres, A Eigler, M Schnurr, and M Dauer. 2014. “P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model.” Journal for Immunotherapy of Cancer 2 (Suppl 2): P1. doi:10.1186/2051-1426-2-S2-P1. http://dx.doi.org/10.1186/2051-1426-2-S2-P1.2051-1426http://nrs.harvard.edu/urn-3:HUL.InstRepos:12406752en-USP10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma modelOther2014-07-0710.1186/2051-1426-2-S2-P1